Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$8.86M Sell
45,504
-1,319
-3% -$257K 2.41% 8
2018
Q3
$9.71M Sell
46,823
-1,430
-3% -$282K 2.12% 10
2018
Q2
$8.91M Buy
48,253
+1,143
+2% +$202K 2.01% 15
2018
Q1
$8.03M Buy
47,110
+1,484
+3% +$272K 1.87% 25
2017
Q4
$7.93M Buy
45,626
+22
+0% +$3.89K 1.9% 31
2017
Q3
$8.5M Sell
45,604
-176
-0.4% -$31.2K 2.05% 12
2017
Q2
$7.88M Buy
+45,780
New +$7.45M 1.94% 18

Other funds holding AMGN

Evanston Advisors's AMGN Position: Q4 2018 in Review

Evanston Advisors reduced its Amgen (AMGN) stake by 2.8% in Q4 2018, selling an estimated $257K and leaving 45,504 shares worth $8.86M. The position accounts for 2.41% of the portfolio, ranked #8.

Evanston Advisors first reported a position in AMGN in Q2 2017 and has held it in 7 quarters since. The position peaked at $9.71M in Q3 2018. 1,891 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

  • Evanston Advisors held 45,504 shares of Amgen worth $8.86M as of Q4 2018.
  • Evanston Advisors sold 1,319 Amgen shares in Q4 2018, an estimated $257K.
  • Amgen made up 2.41% of Evanston Advisors's portfolio in Q4 2018, its #8 holding.
  • Evanston Advisors first reported a position in Amgen in Q2 2017 and has held it in 7 quarters since.
  • Evanston Advisors's Amgen position peaked at $9.71M in Q3 2018.
  • 1,891 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on Evanston Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.